Carotid atherosclerosis is a major cause of stroke. Hemodynamic forces, such as shear stress and oscillatory shear, play an important role in the initiation and progression of atherosclerosis. The alteration of the immune microenvironment is the fundamental pathological mechanism by which diverse external environmental factors impact the formation and progression of plaques. However, Current research on the relationship between hemodynamics and immunity in atherosclerosis still lack of comprehensive understanding. In this study, we combined computational fluid dynamics (CFD) and Mass cytometry (CyTOF) technologies to explore the changes in the immune microenvironment within plaques under different hemodynamic conditions. Our results indicated that neutrophils were enriched in adverse flow environments. M2-like CD163+CD86+ macrophages were predominantly enriched in high WSS and low OSI environments, while CD163-CD14+ macrophages were enriched in low WSS and high OSI environments. Functional analysis further revealed T cell pro-inflammatory activation and dysregulation in modulation, along with an imbalance in M1-like/M2-like macrophages, suggesting their potential involvement in the progression of atherosclerotic lesions mediated by adverse flow patterns. Our study elucidated the potential mechanisms by which hemodynamics regulated the immune microenvironment within plaques, providing intervention targets for future precision therapies.
FeiginVLNorrvingBMensahGA.Global burden of stroke. Circ Res2017;
120: 439–448.
2.
MozaffarianDBenjaminEJGoAS, et al.
Heart disease and stroke statistics – 2016 update: a report from the American Heart Association. Circulation2016;
133: e38-360–360.
3.
WardlawJMSmithCDichgansM.Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol2013;
12: 483–497.
4.
GuptaABaradaranHSchweitzerAD, et al.
Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke2013;
44: 3071–3077.
5.
LorenzMWMarkusHSBotsML, et al.
Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation2007;
115: 459–467.
6.
ChiuJJChienS.Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev2011;
91: 327–387.
7.
GimbroneMAJrandGarcía-CardeñaG.Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res2016;
118: 620–636.
8.
MalekAMAlperSLIzumoS.Hemodynamic shear stress and its role in atherosclerosis. JAMA1999;
282: 2035–2042.
9.
ChengCTempelDvan HaperenR, et al.
Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation2006;
113: 2744–2753.
10.
WinkelsHEhingerEVassalloM, et al.
Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry. Circ Res2018;
122: 1675–1688.
11.
HanssonGKHermanssonA.The immune system in atherosclerosis. Nat Immunol2011;
12: 204–212.
12.
RoyPOrecchioniMLeyK.How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat Rev Immunol2022;
22: 251–265.
13.
BirchallDZamanAHackerJ, et al.
Analysis of haemodynamic disturbance in the atherosclerotic carotid artery using computational fluid dynamics. Eur Radiol2006;
16: 1074–1083.
14.
KumarAHungOYPiccinelliM, et al.
Low coronary wall shear stress is associated with severe endothelial dysfunction in patients with nonobstructive coronary artery disease. JACC Cardiovasc Interv2018;
11: 2072–2080.
15.
AndelovicKWinterPKampfT, et al.
2D projection maps of WSS and OSI reveal distinct spatiotemporal changes in hemodynamics in the murine aorta during ageing and atherosclerosis. Biomedicines2021;
9: 1856.
16.
HartmannFJMrdjenDMcCaffreyE, et al.
Single-cell metabolic profiling of human cytotoxic T cells. Nat Biotechnol2021;
39: 186–197.
17.
QianLGuoT.Immunometabolism the CyTOF way. Immunity2021;
54: 610–613.
18.
SuzukiTTakaoHSuzukiT, et al.
Determining the presence of thin-walled regions at high-pressure areas in unruptured cerebral aneurysms by using computational fluid dynamics. Neurosurgery2016;
79: 589–595.
19.
LiBLiuTLiuJ, et al.
Reliability of using generic flow conditions to quantify aneurysmal haemodynamics: a comparison against simulations incorporating boundary conditions measured in vivo. Comput Methods Programs Biomed2022;
225: 107034.
20.
MurrayCD.The physiological principle of minimum work: I. The vascular system and the cost of blood volume. Proc Natl Acad Sci U S A1926;
12: 207–214.
21.
GroenHCSimonsLvan den BouwhuijsenQJ, et al.
MRI-based quantification of outflow boundary conditions for computational fluid dynamics of stenosed human carotid arteries. J Biomech2010;
43: 2332–2338.
22.
EshtehardiPMcDanielMCSuoJ, et al.
Association of coronary wall shear stress with atherosclerotic plaque burden, composition, and distribution in patients with coronary artery disease. J Am Heart Assoc2012;
1: e002543.
23.
SamadyHEshtehardiPMcDanielMC, et al.
Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery disease. Circulation2011;
124: 779–788.
24.
EshtehardiPBrownAJBhargavaA, et al.
High wall shear stress and high-risk plaque: an emerging concept. Int J Cardiovasc Imaging2017;
33: 1089–1099.
25.
DomaninMBuoraAScardullaF, et al.
Computational fluid-dynamic analysis after carotid endarterectomy: patch graft versus direct suture closure. Ann Vasc Surg2017;
44: 325–335.
26.
XiangJNatarajanSKTremmelM, et al.
Hemodynamic-morphologic discriminants for intracranial aneurysm rupture. Stroke2011;
42: 144–152.
27.
DaviesPFPolacekDCHandenJS, et al.
A spatial approach to transcriptional profiling: mechanotransduction and the focal origin of atherosclerosis. Trends Biotechnol1999;
17: 347–351.
28.
PeifferVSherwinSJWeinbergPD.Does low and oscillatory wall shear stress correlate spatially with early atherosclerosis? A systematic review. Cardiovasc Res2013;
99: 242–250.
29.
SunZXuL.Computational fluid dynamics in coronary artery disease. Comput Med Imaging Graph2014;
38: 651–663.
30.
RidkerPMEverettBMThurenT, et al.
Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med2017;
377: 1119–1131.
31.
ChoiHDeyAKPriyamvaraA, et al.
Role of periodontal infection, inflammation and immunity in atherosclerosis. Curr Probl Cardiol2021;
46: 100638.
32.
StehbensWE.The role of hemodynamics in the pathogenesis of atherosclerosis. Prog Cardiovasc Dis1975;
18: 89–103.
33.
AndoJYamamotoK.Hemodynamic forces, endothelial mechanotransduction, and vascular diseases. Magn Reson Med Sci2022;
21: 258–266.
34.
WangSWangBShiY, et al.
Mechanosensation by endothelial PIEZO1 is required for leukocyte diapedesis. Blood2022;
140: 171–183.
35.
LiuJZhaoCXiaoX, et al.
Endothelial discoidin domain receptor 1 senses flow to modulate Yap activation. Nat Commun2023;
14: 6457.
36.
MehtaVPangKLRozbeskyD, et al.
The guidance receptor plexin D1 is a mechanosensor in endothelial cells. Nature2020;
578: 290–295.
37.
HeMMartinMMarinT, et al.
Endothelial mechanobiology. APL Bioeng2020;
4: 010904.
38.
ChengHZhongWWangL, et al.
Effects of shear stress on vascular endothelial functions in atherosclerosis and potential therapeutic approaches. Biomed Pharmacother2023;
158: 114198.
39.
ZhouJLiYSChienS.Shear stress-initiated signaling and its regulation of endothelial function. Arterioscler Thromb Vasc Biol2014;
34: 2191–2198.
40.
AdamsteinNHMacFadyenJGRoseLM, et al.
The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J2021;
42: 896–903.
41.
GomezIWardBSouilholC, et al.
Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium. Nat Commun2020;
11: 214.
42.
ZhouX.CD4+ T cells in atherosclerosis. Biomed Pharmacother2003;
57: 287–291.
43.
SaigusaRWinkelsHLeyK.T cell subsets and functions in atherosclerosis. Nat Rev Cardiol2020;
17: 387–401.
44.
TyrrellDJGoldsteinDR.Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6. Nat Rev Cardiol2021;
18: 58–68.
45.
McLarenJERamjiDP.Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev2009;
20: 125–135.
46.
BoussiotisVA.Molecular and biochemical aspects of the PD-1 checkpoint pathway. N Engl J Med2016;
375: 1767–1778.
47.
GetzGSReardonCA.Natural killer T cells in atherosclerosis. Nat Rev Cardiol2017;
14: 304–314.
48.
GilmoreTD.Introduction to NF-kappaB: players, pathways, perspectives. Oncogene2006;
25: 6680–6684.
49.
WanFLenardoMJ.The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Res2010;
20: 24–33.
50.
MooreKJSheedyFJFisherEA.Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol2013;
13: 709–721.
51.
Chinetti-GbaguidiGColinSStaelsB.Macrophage subsets in atherosclerosis. Nat Rev Cardiol2015;
12: 10–17.
52.
FangFXiaoCLiC, et al.
Tuning macrophages for atherosclerosis treatment. Regen Biomater2023;
10: rbac103.
53.
YangSYuanHQHaoYM, et al.
Macrophage polarization in atherosclerosis. Clin Chim Acta2020;
501: 142–146.
54.
RaderDJPuréE.Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell?Cell Metab2005;
1: 223–230.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
